US Patent 12077544 Irreversible inhibitors of menin-MLL interaction
Patent 12077544 was granted and assigned to Biomea Fusion, Inc. on September, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12077544 Irreversible inhibitors of menin-MLL interaction
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
